Balchem Corporation — Third Quarter 2026 Earnings Summary

Balchem Corporation reported third-quarter 2026 net sales of $290.7 million, representing an 8.6% increase from the prior year period. The company achieved GAAP net earnings of $46.7 million and adjusted EBITDA of $80.3 million, with all three reporting segments—Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products—showing sales and earnings growth. Free cash flow for the quarter totaled $57.9 million, while the company repurchased approximately $28 million of common stock. Consolidated gross margin improved to 36.4% of sales, driven by sales growth, favorable product mix, and manufacturing efficiencies.